Literature DB >> 33526559

Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis.

Junfeng Zou1, Chen Liu1, Shu Jiang1, Dawei Qian1, Jinao Duan1.   

Abstract

Ulcerative colitis (UC), a nonspecific inflammatory disease, is characterized by inflammation and mucosal damage in the colon, and its prevalence in the world is increasing. Nevertheless, the exact pathogenesis of UC is still unclear. Accumulating data have suggested that its pathogenesis is multifactorial, involving genetic predisposition, environmental factors, microbial dysbiosis, and dysregulated immune responses. Generally, UC is aroused by inappropriate immune activation based on the interaction of host and intestinal microbiota. The relationship between microbiota and host immune system in the pathogenesis of UC is complicated. However, increasing evidence indicates that the shift of microbiota composition can substantially influence intestinal immunity. In this review, we primarily focus on the delicate balance between microbiota and gut mucosal immunity during UC progression.

Entities:  

Keywords:  gut microbiota; mucosal immunity; ulcerative colitis

Mesh:

Year:  2021        PMID: 33526559      PMCID: PMC8370674          DOI: 10.1128/IAI.00014-21

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  183 in total

1.  Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFNγ.

Authors:  Elizabeth R Mann; David Bernardo; Siew C Ng; Rachael J Rigby; Hafid O Al-Hassi; Jon Landy; Simon T C Peake; Henning Spranger; Nicholas R English; Linda V Thomas; Andrew J Stagg; Stella C Knight; Ailsa L Hart
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

2.  [Researches on the change of intestinal barrier function in patients with ulcerative colitis].

Authors:  Tao Shi; Jiangpeng Wei; Gang Liu; Mei Han; Tong Liu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2015-06-23

3.  Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.

Authors:  Ji Li; Aito Ueno; Miriam Fort Gasia; Joanne Luider; Tie Wang; Christina Hirota; Humberto B Jijon; Mailin Deane; Michael Tom; Ronald Chan; Herman W Barkema; Paul L Beck; Gilaad G Kaplan; Remo Panaccione; Jiaming Qian; Marietta Iacucci; Xinyang Gui; Subrata Ghosh
Journal:  Inflamm Bowel Dis       Date:  2016-08       Impact factor: 5.325

Review 4.  Intestinal epithelial cells: regulators of barrier function and immune homeostasis.

Authors:  Lance W Peterson; David Artis
Journal:  Nat Rev Immunol       Date:  2014-03       Impact factor: 53.106

5.  Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages.

Authors:  Christoph S N Klose; Melanie Flach; Luisa Möhle; Leif Rogell; Thomas Hoyler; Karolina Ebert; Carola Fabiunke; Dietmar Pfeifer; Veronika Sexl; Diogo Fonseca-Pereira; Rita G Domingues; Henrique Veiga-Fernandes; Sebastian J Arnold; Meinrad Busslinger; Ildiko R Dunay; Yakup Tanriver; Andreas Diefenbach
Journal:  Cell       Date:  2014-04-10       Impact factor: 41.582

6.  Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation.

Authors:  Sidhartha R Sinha; Yeneneh Haileselassie; Linh P Nguyen; Carolina Tropini; Min Wang; Laren S Becker; Davis Sim; Karolin Jarr; Estelle T Spear; Gulshan Singh; Hong Namkoong; Kyle Bittinger; Michael A Fischbach; Justin L Sonnenburg; Aida Habtezion
Journal:  Cell Host Microbe       Date:  2020-02-25       Impact factor: 21.023

7.  Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative Colitis.

Authors:  Julia Fritsch; Luis Garces; Maria A Quintero; Judith Pignac-Kobinger; Ana M Santander; Irina Fernández; Yuguang J Ban; Deukwoo Kwon; Matthew C Phillips; Karina Knight; Qingqing Mao; Rebeca Santaolalla; Xi S Chen; Mukil Maruthamuthu; Norma Solis; Oriana M Damas; David H Kerman; Amar R Deshpande; John E Lewis; Chi Chen; Maria T Abreu
Journal:  Clin Gastroenterol Hepatol       Date:  2020-05-20       Impact factor: 13.576

Review 8.  The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants' life: a systematic review.

Authors:  Erigene Rutayisire; Kun Huang; Yehao Liu; Fangbiao Tao
Journal:  BMC Gastroenterol       Date:  2016-07-30       Impact factor: 3.067

9.  Carrageenan Gum and Adherent Invasive Escherichia coli in a Piglet Model of Inflammatory Bowel Disease: Impact on Intestinal Mucosa-associated Microbiota.

Authors:  Peris M Munyaka; Shadi Sepehri; Jean-Eric Ghia; Ehsan Khafipour
Journal:  Front Microbiol       Date:  2016-04-05       Impact factor: 5.640

10.  Fungal microbiota dysbiosis in IBD.

Authors:  Harry Sokol; Valentin Leducq; Hugues Aschard; Hang-Phuong Pham; Sarah Jegou; Cecilia Landman; David Cohen; Giuseppina Liguori; Anne Bourrier; Isabelle Nion-Larmurier; Jacques Cosnes; Philippe Seksik; Philippe Langella; David Skurnik; Mathias L Richard; Laurent Beaugerie
Journal:  Gut       Date:  2016-02-03       Impact factor: 23.059

View more
  5 in total

1.  The Alleviation of Gut Microbiota-Induced Depression and Colitis in Mice by Anti-Inflammatory Probiotics NK151, NK173, and NK175.

Authors:  Jong-Wook Yoo; Yoon-Jung Shin; Xiaoyang Ma; Young-Hoo Son; Hyo-Min Jang; Chang Kyun Lee; Dong-Hyun Kim
Journal:  Nutrients       Date:  2022-05-16       Impact factor: 6.706

Review 2.  Tea Polyphenols: A Natural Antioxidant Regulates Gut Flora to Protect the Intestinal Mucosa and Prevent Chronic Diseases.

Authors:  Xinzhou Wang; Yanan Liu; Zufang Wu; Peng Zhang; Xin Zhang
Journal:  Antioxidants (Basel)       Date:  2022-01-28

Review 3.  Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies.

Authors:  Jelena Popov; Valentina Caputi; Nandini Nandeesha; David Avelar Rodriguez; Nikhil Pai
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

4.  Fibromodulin Ablation Exacerbates the Severity of Acute Colitis.

Authors:  Marianna Halasi; Mor Grinstein; Avner Adini; Irit Adini
Journal:  J Inflamm Res       Date:  2022-08-08

5.  An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis.

Authors:  Manuel Ponce-Alonso; Carlota García-Hoz; Ana Halperin; Javier Nuño; Pilar Nicolás; Adolfo Martínez-Pérez; Juan Ocaña; Juan Carlos García-Pérez; Antonio Guerrero; Antonio López-Sanromán; Rafael Cantón; Garbiñe Roy; Rosa Del Campo
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.